Skip to main content
SVBI logo

SVBI — Investor Relations & Filings

Ticker · 1786 ISIN · TW0001786002 TW Manufacturing
Open in API
Filings indexed 1,687 across all filing types
Latest filing 2019-03-28 Regulatory Filings
Country TW Taiwan
Listing TW 1786

About SVBI

www.scivision.com.tw

SciVision Biotech Inc. is a specialized developer and manufacturer of advanced medical devices, focusing on the research and production of hyaluronic acid (HA) products. The company leverages its proprietary Crosslinked Hyaluronic Acid Platform (CHAP) technology to create high-performance solutions across multiple medical disciplines. Its core product portfolio includes subcutaneous fillers for facial aesthetics, intra-articular injections for orthopedic joint care, anti-adhesion gels for surgical applications, and vesical instillation solutions for urological treatments. By integrating specialized R&D capabilities with precision manufacturing, SciVision Biotech provides medical-grade HA applications designed to improve patient outcomes in aesthetics and therapeutic recovery. The company is committed to scientific innovation and the expansion of its patented technology to meet diverse clinical needs in the global healthcare market.

Recent filings

Filing Released Lang Actions
107年第4季海外子公司投資
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure related to investment in overseas subsidiaries, showing investment amounts, holding percentages, and recognized investment gains or losses for a specific quarter (107th year, 4th quarter). It is very short (664 characters) and contains tabular data about investments but does not include comprehensive financial statements or detailed analysis. It appears to be a regulatory disclosure or announcement rather than a full financial report. There is no indication that this is an annual or interim report, audit report, or earnings release. Given the short length and nature of the content, it fits best as a Regulatory Filing (RNS), which is a fallback category for miscellaneous filings that do not fit other specific categories.
2019-03-28 Chinese
107年第4季大陸投資
Regulatory Filings Classification · 90% confidence The document is a detailed tabular disclosure of investment amounts and related financial data concerning investments in mainland China by a Taiwanese listed company. It includes specific financial figures, investment methods, and regulatory limits, referencing the Economic Ministry's investment approval and limits. The content is focused on investment details rather than a general financial report or announcement. The document length is short (1293 characters), but it contains substantive financial data related to investments, not just an announcement or certification. This type of disclosure aligns with regulatory filings related to investment disclosures, which do not fit into other specific categories like Annual Report or Interim Report. Therefore, the best classification is Regulatory Filings (RNS), as it is a regulatory disclosure document that does not fit other categories.
2019-03-28 Chinese
公告董事會決議召開108年股東常會相關事宜
AGM Information Classification · 95% confidence The document is a public announcement from a listed company (1786 科妍) regarding the board resolution to convene the 108th Annual General Meeting (AGM). It details the date and location of the AGM, agenda items including reports, approvals, discussions, elections, and other procedural matters. The document does not contain the actual AGM materials or reports but announces the meeting and its agenda. The document length is short (1224 characters), and it serves as a notice of the AGM rather than the AGM report or presentation itself. Therefore, it fits the category of AGM Information (AGM-R).
2019-03-28 Chinese
公告董事會決議股利分派
Notice of Dividend Amount Classification · 100% confidence The document is a short announcement (690 characters) from a company regarding a board resolution on dividend distribution, including details on cash dividends and amounts. It does not contain full financial statements or detailed reports but rather a specific announcement about dividend decisions made by the board. This fits the definition of a Notice of Dividend Amount (DIV).
2019-03-28 Chinese
107年度股利金額(董事會決議)
Notice of Dividend Amount Classification · 95% confidence The document text is a detailed announcement of dividend distribution information for a company, including dividend amounts, dates, and related notes. It does not contain a full financial report or comprehensive financial statements. The content focuses specifically on dividend amounts and payment details, which aligns with the definition of a Notice of Dividend Amount (DIV). The document length is short (1899 characters), and it is not an announcement of a report publication but the actual dividend distribution details. Therefore, the appropriate classification is DIV.
2019-03-28 Chinese
107年第4季現金流量表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated cash flow statement for the fourth quarter of the 107th year (likely referring to a fiscal year in the Taiwanese calendar, corresponding to 2018). It includes detailed financial data such as cash flows from operating, investing, and financing activities, with specific monetary amounts and accounting items. The document is 2529 characters long, which is relatively short but contains substantive financial data rather than just an announcement or a certification. The presence of detailed financial statements for a quarterly period indicates this is an Interim / Quarterly Report (IR). FY 2018
2019-03-28 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.